Cited by 56Heart Failure Treatment and ManagementThyroid Disorders and TreatmentsHormonal and reproductive studies

Usefulness of serum triiodothyronine (T3) to predict outcomes in patients hospitalized with acute heart failure

Rothberger, Gary D., Gadhvi, Sonya, Michelakis, Nickolaos, Kumar, Amit, Calixte, Rose, Shapiro, Lawrence E.·2017·The American Journal of Cardiology

Abstract

Thyroid hormone plays an important role in cardiac function. Low levels of serum triiodothyronine (T 3) due to nonthyroidal illness syndrome may have adverse effects in heart failure (HF). This study was designed to assess the ability of T 3 to predict in-hospital outcomes in patients with acute HF. In total, 137 patients without thyroid disease or treatment with drugs which affect TH levels, who were hospitalized with acute HF were prospectively enrolled and studied. TH levels were tested upon hospital admission, and outcomes were compared between patients with low (<2.3 pg/ml) and normal (≥2.3 pg/ml) free T 3 levels as well as between those with low (<0.6 ng/ml) and normal (≥0.6 ng/ml) total T 3 levels. Low free T 3 correlated with an increased length of stay in the hospital (median 11 vs 7 days, p <0.001) and higher rates of intensive care unit admission (31.8% vs 16.9%, p = 0.047), with a trend toward increased need for invasive mechanical ventilation (9.0% vs 1.4%, p = 0.056). Low total T3 correlated with an increased length of stay in the hospital (median 11 vs 7 days, p <0.001) and increased need for invasive mechanical ventilation (9.8% vs 1.3%, p = 0.045). In conclusion, low T 3 predicts worse hospital outcomes in patients with acute HF and can be useful in the risk stratification of these patients.

Integrity signals

Registry

Crossref · 10.1016/j.amjcard.2016.10.045

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Thyroid hormone metabolism alterations are associated with worse prognosis in patients with ischemic and nonischemic left ventricular dysfunction in both acute decompensated and chronic stable heart failure.

    “Furthermore, in addition to conventional risk factors, TH metabolism alterations have been associated with a worse prognosis in patients with both ischemic and nonischemic LV dysfunction in both acute decompensated and chronic stable HF (131-133).”

    From Thyroid Hormones and Cardiovascular Function and Diseases (2018) · cites this paper as [133]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rothberger, G. D., Gadhvi, S., Michelakis, N., Kumar, A., Calixte, R., & Shapiro, L. E.
Affiliations
Winthrop-University Hospital (US)
Corresponding author
Rothberger, Gary D.
Venue
The American Journal of Cardiology
Publisher
Elsevier BV
Published
2017-02
Volume
119
Issue
4
Pages
599-603
ISSN
0002-9149 (ISSN-L)
OpenAlex
W2553704292
Cited by
56
References
29
Citations by year
2026: 3 · 2025: 1 · 2024: 6 · 2023: 6 · 2022: 3 · 2021: 14 · 2020: 9 · 2019: 9 · 2018: 4 · 2017: 1
FWCI
3.85
Type
journal article
Language
en
Open access
closed
Locations
  • The American Journal of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
serum triiodothyronine, acute heart failure, low T3 syndrome, thyroid hormones, prognostic factors, length of hospital stay, intensive care unit admission, invasive mechanical ventilation, risk stratification
MeSH terms
Acute Disease, Aged, Aged, 80 and over, Euthyroid Sick Syndromes, Female, Heart Failure, Hospitalization, Humans, Intensive Care Units, Length of Stay, Male, Middle Aged, Prognosis, Prospective Studies, Respiration, Artificial, Triiodothyronine, Cohort Studies, Linear Models

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review